Stay updated on KarXT Long-Term Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.

Latest updates to the KarXT Long-Term Safety in Schizophrenia Clinical Trial page
- Check4 days agoChange DetectedAdded a MedlinePlus Genetics topic on Schizophrenia and updated the page revision from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.3%
- Check11 days agoChange DetectedThe page has been updated to version 3.0.1, and the previous version 3.0.0 has been removed. Additionally, the topic of Schizophrenia related to MedlinePlus Genetics has been deleted.SummaryDifference0.3%
- Check18 days agoChange DetectedThe web page has undergone significant changes, including the addition of specific facility names and locations, as well as the introduction of new drug names such as Trospium Chloride and xanomeline. The revision number has also been updated to v3.0.0.SummaryDifference2%
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to KarXT Long-Term Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.